secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2022-10-27T23:59:59+00:00
Accession:  0001193125-22-271105
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences effects 1-for-15 reverse stock split, reduces authorized shares to 60M
--------------------------------------------------------------------------------

- 1-for-15 reverse stock split effective Oct. 27, 2022; trading on split-adjusted basis begins Oct. 28.
- Authorized common shares reduced from 300M to 60M (20M post-split then tripled per certificate amendment).
- Stockholders approved the amendment at the June 7, 2022 annual meeting; no fractional shares, cash in lieu.
- Outstanding options, warrants, and RSUs adjusted proportionally per their terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312522271105/0001193125-22-271105-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312522271105/d346984d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-271105

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer